MONTAUK RENEWABLES INC (MNTK) Fundamental Analysis & Valuation

NASDAQ:MNTK • US61218C1036

1.405 USD
-0.12 (-8.17%)
Last: Mar 10, 2026, 08:00 PM

This MNTK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

MNTK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of MNTK have multiple concerns. MNTK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. MNTK Profitability Analysis

1.1 Basic Checks

  • In the past year MNTK has reported negative net income.
  • In the past year MNTK had a positive cash flow from operations.
  • Of the past 5 years MNTK 4 years were profitable.
  • MNTK had a positive operating cash flow in each of the past 5 years.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • With a Return On Assets value of -2.40%, MNTK is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
  • MNTK's Return On Equity of -3.53% is in line compared to the rest of the industry. MNTK outperforms 45.00% of its industry peers.
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROIC N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • MNTK's Profit Margin has been stable in the last couple of years.
  • MNTK's Operating Margin has declined in the last couple of years.
  • The Gross Margin of MNTK (34.69%) is worse than 60.00% of its industry peers.
  • MNTK's Gross Margin has been stable in the last couple of years.
  • MNTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.69%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

2

2. MNTK Health Analysis

2.1 Basic Checks

  • MNTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MNTK has been increased compared to 1 year ago.
  • MNTK has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MNTK has been reduced compared to a year ago.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that MNTK is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.54, MNTK is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • MNTK has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • MNTK has a Debt to Equity ratio of 0.21. This is in the better half of the industry: MNTK outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACCN/A
WACC8.09%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 0.33 indicates that MNTK may have some problems paying its short term obligations.
  • The Current ratio of MNTK (0.33) is worse than 95.00% of its industry peers.
  • MNTK has a Quick Ratio of 0.33. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.33, MNTK is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. MNTK Growth Analysis

3.1 Past

  • The earnings per share for MNTK have decreased strongly by -140.00% in the last year.
  • MNTK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.33% yearly.
  • Looking at the last year, MNTK shows a very negative growth in Revenue. The Revenue has decreased by -17.54% in the last year.
  • Measured over the past years, MNTK shows a quite strong growth in Revenue. The Revenue has been growing by 10.70% on average per year.
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.34% on average over the next years.
  • MNTK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.09% yearly.
EPS Next Y-66%
EPS Next 2Y-3.3%
EPS Next 3Y37.62%
EPS Next 5Y6.34%
Revenue Next Year-13.63%
Revenue Next 2Y-0.2%
Revenue Next 3Y5.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3

2

4. MNTK Valuation Analysis

4.1 Price/Earnings Ratio

  • MNTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • MNTK is valuated quite expensively with a Price/Forward Earnings ratio of 25.04.
  • MNTK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MNTK is cheaper than 75.00% of the companies in the same industry.
  • MNTK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.39.
Industry RankSector Rank
PE N/A
Fwd PE 25.04
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MNTK indicates a somewhat cheap valuation: MNTK is cheaper than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.95
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MNTK's earnings are expected to grow with 37.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.3%
EPS Next 3Y37.62%

0

5. MNTK Dividend Analysis

5.1 Amount

  • No dividends for MNTK!.
Industry RankSector Rank
Dividend Yield 0%

MNTK Fundamentals: All Metrics, Ratios and Statistics

MONTAUK RENEWABLES INC

NASDAQ:MNTK (3/10/2026, 8:00:01 PM)

1.405

-0.12 (-8.17%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-05
Earnings (Next)03-11
Inst Owners16.28%
Inst Owner Change-5.19%
Ins Owners53.73%
Ins Owner Change0%
Market Cap201.14M
Revenue(TTM)160.68M
Net Income(TTM)-9.20M
Analysts74.55
Price Target3.23 (129.89%)
Short Float %3.5%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.81%
Min EPS beat(2)-413.72%
Max EPS beat(2)180.11%
EPS beat(4)1
Avg EPS beat(4)-139.36%
Min EPS beat(4)-413.72%
Max EPS beat(4)180.11%
EPS beat(8)3
Avg EPS beat(8)-76.06%
EPS beat(12)3
Avg EPS beat(12)-77.59%
EPS beat(16)3
Avg EPS beat(16)-69.3%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)1.62%
Revenue beat(4)1
Avg Revenue beat(4)-13.09%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)1.62%
Revenue beat(8)2
Avg Revenue beat(8)-11.35%
Revenue beat(12)3
Avg Revenue beat(12)-12.63%
Revenue beat(16)5
Avg Revenue beat(16)-7.61%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)300%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.04
P/S 1.25
P/FCF N/A
P/OCF 6.55
P/B 0.77
P/tB 0.84
EV/EBITDA 11.95
EPS(TTM)-0.06
EYN/A
EPS(NY)0.06
Fwd EY3.99%
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.21
OCFY15.27%
SpS1.12
BVpS1.82
TBVpS1.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.69%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 302.02%
Cap/Sales 52.34%
Interest Coverage N/A
Cash Conversion 131.56%
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 1.54
F-Score3
WACC8.09%
ROIC/WACCN/A
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
EPS Next Y-66%
EPS Next 2Y-3.3%
EPS Next 3Y37.62%
EPS Next 5Y6.34%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%
Revenue Next Year-13.63%
Revenue Next 2Y-0.2%
Revenue Next 3Y5.09%
Revenue Next 5YN/A
EBIT growth 1Y-112.86%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year2.28%
EBIT Next 3Y22.59%
EBIT Next 5Y5.16%
FCF growth 1Y-278.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.8%
OCF growth 3Y0.71%
OCF growth 5Y9.49%

MONTAUK RENEWABLES INC / MNTK FAQ

What is the ChartMill fundamental rating of MONTAUK RENEWABLES INC (MNTK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MNTK.


Can you provide the valuation status for MONTAUK RENEWABLES INC?

ChartMill assigns a valuation rating of 2 / 10 to MONTAUK RENEWABLES INC (MNTK). This can be considered as Overvalued.


How profitable is MONTAUK RENEWABLES INC (MNTK) stock?

MONTAUK RENEWABLES INC (MNTK) has a profitability rating of 2 / 10.


What is the expected EPS growth for MONTAUK RENEWABLES INC (MNTK) stock?

The Earnings per Share (EPS) of MONTAUK RENEWABLES INC (MNTK) is expected to decline by -66% in the next year.